3,4-dihydroxyphenylacetic acid has been researched along with cycloserine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Dall'Olio, R; Gandolfi, O; Rimondini, R | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and cycloserine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
D-cycloserine decreases both D1 and D2 dopamine receptors number and their function in rat brain.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Cell Membrane; Cycloserine; Dizocilpine Maleate; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Ergolines; In Vitro Techniques; Kinetics; Male; Neostriatum; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Spiperone | 1994 |